イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text



Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Cell Culture & Characterization
No items found.

ブログ
Revealing the Unknown: How the COVID Active Research Experience (CARE) Registry is Enhancing Community Health
2月 24, 2021
ブログを読む
Real-World Data (RWD)
No items found.
Pharmacology
Disease Models
No items found.
Health Economics & Outcomes Research (HEOR)
Market Access
Real-World Evidence (RWE)
No items found.

ブログ
Maximize Your Chances of Success: Avoid and Mitigate Risk of Failure When Developing Biotherapeutics
2月 10, 2021
ブログを読む
Pharmacology
No items found.
Health Economics & Outcomes Research (HEOR)
No items found.

ブログ
Biotech 2050 Podcast: Revolutionizing the Drug Discovery Marketplace With Kevin Lustig, Founder and CEO, Scientist.com
2月 4, 2021
ブログを読む
Pharmacology
No items found.
Disease Models
No items found.
Disease Models
No items found.
Protein Sciences
Pharmacology
In Vitro Assays
No items found.
Bioimaging
Cell Culture & Characterization
Discovery Chemistry
In Vitro Assays
Instrumentation & Products
Brice Murciano
Céline Ronin
Marc Vitorino
Novalix
No items found.
Bioimaging
Discovery Chemistry
Disease Models
In Vitro Assays
Protein Sciences
Babatunde Ekundayo
KACTUS
No items found.
Pharmacology
Cell Culture & Characterization
Marta Costa
STEMCELL Technologies Inc.
No items found.
Disease Models
Toxicology
Pharmacology
DMPK
In Vitro Assays
Courtney Noah
René Overmeer
Paul Walker
BioIVT
HUB Organoids
Evotec
Scientist.com
HBS
Real-World Data (RWD)
Pharmacology
Clinical Trials
Nicolas Weinbreck
Caroline Rancati
Pauline Mespoulhé
France Tissue Bank
No items found.
Disease Models
Pharmacology
Kosuke Hitaka
Shuichi Takagahara
Axcelead Drug Discovery Partners, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Disease Models
Simote T. Foliaki
Harvard Bioscience, Inc.
No items found.
Disease Models
Instrumentation & Products
Karyn Esser
Aurora Scientific, Inc.
American Physiological Society
Pharmacology
Disease Models
Catherine Robin-Jagerschmidt
Didier Merciris
Vincent Dumont
Novalix
Scientist.com

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.
































.avif)








